Piramal Healthcare Ltd
Piramal Pharma Solutions is the Contract Development and Manufacturing (CDMO) arm of Piramal Healthcare and is one of the only CDMOs providing support throughout the entire pharmaceutical drug product life-cycle. We also provide specialty services of Antibody Drug Conjugation & Clinical Trial Supplies for Pharmaceutical Companies across geographies.
Antibody Drug Conjugates (ADCs):
Piramal Pharma Solutions has made over 300 batches of ADCs spanning over more than 30 different NCEs. We leverage this unparalleled experience to shorten development timelines whilst delivering robust processes for ADCs.
- Process development, optimization and characterization
- Pre-clinical and toxicology batch preparations
- GMP manufacture of clinical and commercial supplies
- Analytical and bio-analytical method development, technology transfer & validation
- Stand alone Analytical Services
- Release testing of drug substance and drug product
- Cell based assays
- Stability study design and execution to ICH Q1
- QP release of formulated bulk drug product
Piramal Pharma Solutions supplies products and services through our globally integrated network of sites across North America, Europe and Asia. This structure enables us to offer a comprehensive range of services across the drug lifecycle – from Drug Discovery Solutions, Manufacturing and Packaging of Phase I – III Clinical Trial Supplies through to Commercial Volumes for API and Formulated solid dosage drug product.
Piramal values the relationships with its customers and has established "Customer Centricity" as the driver behind all its actions.
Piramal’s philosophy on intellectual property rights ("IPR") is built on upholding the IP generated by the company and all its associates. The company has set up processes to ensure that it respects the IPR of all its clients, partners and competitors, does not infringe any process or product knowingly and/or unknowingly.
Piramal Pharma Solutions has built a reputation for offering excellent manufacturing capabilities and extremely efficient operating systems that deliver outstanding quality, accredited by USFDA and EU regulatory authorities. Such end to end services & competitive pricing makes Piramal a compelling value proposition to our Global Innovator and Generic Customers.
Dr. Detlef Behrens
VP Business Development, Formulations
VP Business Development, API Services